Evoke Pharma (NASDAQ:EVOK) reported its Q1 earnings results on Tuesday, May 10, 2022 at 04:05 PM.
Here's what investors need to know about the announcement.
Earnings
Evoke Pharma missed estimated earnings by 75.0%, reporting an EPS of $-0.07 versus an estimate of $-0.04.
Revenue was up $327.96 thousand from the same period last year.
Past Earnings Performance
Last quarter the company beat on EPS by $0.02 which was followed by a 12.82% drop in the share price the next day.
Here's a look at Evoke Pharma's past performance:
| Quarter | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
|---|---|---|---|---|
| EPS Estimate | -0.08 | -0.07 | -0.08 | -0.06 |
| EPS Actual | -0.06 | -0.06 | -0.07 | -0.08 |
| Revenue Estimate | 510.00K | 380.00K | 150.00K | 830.00K |
| Revenue Actual | 360.57K | 930.45K | 236.63K | 90.42K |
To track all earnings releases for Evoke Pharma visit their earnings calendar here.
This article was generated by Benzinga's automated content engine and reviewed by an editor.
